M28 Capital ups Adagio Therapeutics holding to 8.5%
M28 Capital has acquired an additional 2.85 million share in Adagio Therapeutics (ADGI) at an average of $4.28 per share, bringing its holding to 9.2 million, according to a report by 247WallStreet. The report cites a 13D/A filing with the








